United StatesÚltimas notícias

Shoe Carnival (NASDAQ:SCVL) announced a sudden leadership transition on Wednesday, naming Vice Chairman and former long-time head Cliff Sifford as interim President and CEO.

United Therapeutics (NASDAQ:UTHR) reported record-breaking financial results for fiscal year 2025 on Wednesday, marking the fourth consecutive year of all-time high revenues.

Chatham Lodging Trust (NYSE:CLDT) revealed on Wednesday a net profit of $3 million for the fourth quarter of 2025, marking a successful turnaround from the $4 million loss recorded during the same period last year.

Valens Semiconductor (NYSE:VLN), a provider of high-speed connectivity semiconductors, on Wednesday reported fourth-quarter revenue of $19.4 million and full-year 2025 revenue of $70.6 million, both exceeding the company's prior guidance ranges.

Recursion (NASDAQ:RXRX) reported fourth-quarter 2025 revenue of $35.5 million on Wednesday, significantly exceeding analyst estimates of $24.6 million.

Amarin (NASDAQ:AMRN) reported a significantly narrowed fourth-quarter loss on Wednesday, bolstered by a global restructuring plan that has repositioned the biopharmaceutical firm for a pivot toward sustainable profitability in 2026.

Aspen Aerogels (NYSE:ASPN) reported a significant financial contraction for fiscal year 2025 on Wednesday, prompting the company to initiate a formal strategic review to optimize its cost structure and evaluate its asset portfolio.

The TJX Companies (NYSE:TJX), the parent of T.J. Maxx, Marshalls, HomeGoods and other off-price retail chains, on Wednesday reported net income of $1.77 billion for its fiscal fourth quarter ended January 31, 2026.

BKV Corp. (NYSE:BKV) reported a definitive return to profitability for the fourth quarter and full fiscal year 2025 on Wednesday, marking a successful first full year as a publicly traded company.

Photronics (NASDAQ:PLAB) reported fiscal first-quarter results Wednesday that surpassed analyst projections, fueled by continued momentum in high-end semiconductor manufacturing.

Ionis Pharmaceuticals (NASDAQ:IONS) on Wednesday reported a net loss of $229 million for its fourth quarter ended December 31, 2025.

Manchester United (NYSE:MANU) reported on Wednesday a net profit of $5.6 million (£4.2 million) for its fiscal second quarter ended December 31, 2025, a significant turnaround from the $34.7 million loss recorded in the same period last year.